An examination of Medicare Part D plans in California and Hawaii reveals wide variations in drug formularies, but indicates that for many classes of drugs, it is possible to find at least one or more drug that is covered by nearly all Part D plans, according to a study in the June 20 issue of JAMA.
Statement on the Ovarian Cancer Symptoms Consensus issued from the Ovarian & Gynecologic Cancer Coalition/Rhonda’s Club and In My Sister’s Care:
A team from Sandia National Laboratories research team led the effort to computerize a new FDA program so that it will be distributed as widely as possible.The downloadable program, called “CARVER + Shock,” provides a series of interactive questions. The program helps companies of any size determine vulnerabilities along their food-processing chain.
A unique nanoparticle made in a laboratory at the University of Central Florida is proving promising as a drug delivery device for treating glaucoma, an eye disease that can cause blindness and affects millions of people worldwide.
A comparison of three parasite species that cause Leishmaniasis has identified a small number of genes, many new to biology, that will provide a framework to target the search for new treatments. Leishmaniasis is a devastating disease that affects about two million people each year and threatens one-fifth of the world’s population and new treatments are desperately needed.
Obesity, high blood pressure, high cholesterol, and inactivity: they?re not just your father?s problems any more, University of New Hampshire research finds. New data on the widely unstudied demographic of college students indicates that this group of 18 ? 24-year-olds are on the path toward chronic health diseases. Although limited, national data suggest the trend is not unique to UNH.
Rare, previously undetectable drug-resistant forms of HIV have been identified by Yale School of Medicine researcher Michael Kozal, M.D., using an innovative genome sequencing technology that quickly detects rare viral mutations.
Penn State Milton S. Hershey Medical Center today announced that James McInerney, M.D., associate professor of neurosurgery, and director of stereotactic and functional neurosurgery, Penn State Hershey Medical Center and Penn State College of Medicine, in collaboration with Elana Farace, Ph.D., neuropsychologist, associate professor of neurosurgery and director of clinical research, will receive the New Investigator Award for their research in vagus nerve stimulation (VNS) therapy at the New Clinical Drug Evaluation Unit (NCDEU) meeting on Monday, June 11, in Boca Raton, Florida.
The National Ovarian Cancer Coalition (NOCC) joins the Gynecologic Cancer Foundation and other national organizations in announcing the first national agreement on ovarian cancer symptoms. Often referred to as the ?silent killer? due to the common belief that there are no warning signs or symptoms, ovarian cancer is the most deadly reproductive cancer.
University of Pennsylvania researchers have created the first three-dimensional optical images of human breast cancer in patients based on tissue fluorescence.